nach oben

Drugs in R&D

Erschienen in:

01.01.2003 | Adis R&D Profile

Ferumoxtran-10

AMI 227, AMI 227cn, AMI 27, BMS 180549, Combidex®, G 53425, Sinerem™

Erschienen in: Drugs in R&D | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Excerpt

Ferumoxtran-10 [AMI 227, AMI 227CN, AMI 27, G 53425, BMS 180549, Sinerem™], consists of iron-oxide particles coated with dextran.¹ It is an ultrasmall superparamagnetic contrast agent that is awaiting registration with Advanced Magnetics (as Combidex®) in the US. …

This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

Advanced Magnetics Inc. Advanced Magnetics, Inc. Reports Fourth Fiscal Quarter And Year End Results. Media Release: 22 Nov 2002. Available from URL: http://www.advancedmagnetics.com

Advanced Magnetics Inc, Cytogen Corporation. National Cancer Institute to Study use of Advanced Magnetics’ MRI Contrast Agents, Combidex(R) and Code 7228, in Detection of Metastatic Lymph Node Disease. Media Release: 30 Sep 2002. Available from URL: http://www.advancedmagnetics.com

Mclachlan SJ, Morris MR, Lucas MA, et al. Phase-I clinical evaluation of a new iron oxide MR contrast agent. JMRI — Journal of Magnetic Resonance Imaging 4: 301–307, May–Jun 1994CrossRef

Small WC, Nelson RC, Bernardino ME. Dual contrast enhancement of both T-1- and T-2-weighted sequences using ultrasmall superparamagnetic iron oxide. Magnetic Resonance Imaging 11: 645–654, No. 5, 1993PubMedCrossRef

Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, et al. Splenic imaging with ultrasmall superparamagnetic iron oxide Ferumoxtran-10 (AMI-7227): preliminary observations. Journal of Computer Assisted Tomography 25: 770–776, Sep–Oct 2001PubMedCrossRef

Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. American Journal of Neuroradiology 23: 510–519, Apr 2002PubMed

Harisinghani M, Barentsz J, Han P, Deserno W, Marten K, et al. MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America: [2 pages], 25 Nov 2001. Available from URL: http://shows.rsna.org

Titel: Ferumoxtran-10
AMI 227, AMI 227cn, AMI 27, BMS 180549, Combidex®, G 53425, Sinerem™
Publikationsdatum: 01.01.2003
Verlag: Springer International Publishing
Erschienen in: Drugs in R&D / Ausgabe 1/2003
Print ISSN: 1174-5886
Elektronische ISSN: 1179-6901
DOI: https://doi.org/10.2165/00126839-200304010-00009

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Ferumoxtran-10

AMI 227, AMI 227cn, AMI 27, BMS 180549, Combidex®, G 53425, Sinerem™

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2003

Profile Summary

Testosterone-Buccal — Columbia

Sitafloxacin

Estradiol-Topical — Novavax

Cinacalcet

Budesonide Hydrofluoroalkane Inhalation — Chiesi